Clinical Trial Update: CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation [NA]

View source ↗

Summary

Clinical trial update indicating that the CellFX nanosecond pulsed field ablation cardiac surgery clamp system is recruiting for treating atrial fibrillation du…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• CellFX Nanosecond Pulsed Field Ablation Cardiac Surgery Clamp System

Snippet

Sponsor: Pulse Biosciences, Inc. | Conditions: Atrial Fibrillation, Maze Procedure | NA | Status: RECRUITING